Case report on Cotard’s syndrome (CS) in a patient with schizophrenia: a rare case from Malaysia

Subhas, Natasha; Naing, Khin Ohnmar; Su, Chaw; Loo, Jiann Lin; Shahbudin, Aishah Farhana; Sivasubramaniam, Vevehkanandar; Thyagarajan, Reenisha

doi:10.1186/s41983-021-00359-4

Cited by 2 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Even though a verdict of Cotard's syndrome does not necessitate the patient to have had hallucinations, the strong delusions of negation are analogous to those found in schizophrenic patients. 11,12…”

Section: Stagesmentioning

confidence: 99%

Cotard’s Delusion-DEAD MAN’S SKETCH

Dipankar Maiti,

Victoria Sarvand

2022

IJPN

View full text Add to dashboard Cite

Cotard'sdelusion (CD) is anerratic psychiatric disorder in which the patient believes to be dead, i.e., the patient holds nihilistic delusions concerning his/her own existence. Taking into justification its rarity, and possible subdiagnosis due to inexperience, most of the literature consists of case studies, confounding a more systematic approach and leading to hitches in deciding the best clinical direction to offer the patient misery from CD. The patient eventuallygrieves from nihilistic delusions that they no lengthier exist. Though the delusional disorder was first recognized in the 17th century by Dr. Jules. It is neither classified under DSM-IV-TR nor ICD-10. There is main three main stages of this disease condition: Germination stage, Blooming stage and Chronic stage. Detecting Cotard delusion is habitually difficult because most organizations don't distinguish it as a disease. Patients habitually receive medication and therapy. Medications used to treat this delusional disorder include: Anti-anxiety, Antidepressants, Antipsychotics, Mood stabilizers medications, Psychotherapy, Play therapy etc. treatment modalitiesNevertheless,Cotard syndrome have been described in connotation with many other affective disorders, it is less often found in patients with catatonia.

show abstract

Section: Stagesmentioning

confidence: 99%

Cotard’s Delusion-DEAD MAN’S SKETCH

Dipankar Maiti,

Victoria Sarvand

2022

IJPN

View full text Add to dashboard Cite

show abstract

Agomelatine/amisulpride/zolpidem

2021

Reactions Weekly

View full text Add to dashboard Cite

Agomelatine/amisulpride/zolpidem Various toxicties: case reportA 42-year-old woman developed parkinsonism, extrapyramidal side effects and amenorrhoea due to hyperprolactinaemia during treatment with amisulpride for schizophrenia and Cotard's syndrome (CS). She felt like a zombie during treatment with agomelatine for major depressive disorder. Additionally, she exhibited lack of efficacy during treatment with agomelatine and zolpidem for major depressive disorder [routes, durations of treatments to reactions onset not stated; not all outcomes stated].The woman in Malaysia presented with various non-specific health ailments. After four years, her overall mental health worsened. Subsequently, a diagnosis of major depressive disorder was confirmed and she received zolpidem 10mg daily and agomelatine 25mg daily. Despite 3 weeks of treatment, her symptoms including insomnia and mental health worsened. She reported that she "felt like a zombie", which was thought to be related to agomelatine. Because of significant physical health worsening, she was admitted to hospital in September 2018. Thereafter, a diagnosis of CS and schizophrenia was made. She demonstrated poor response to risperidone and nihilistic delusions were present while being treated at the hospital. Thereafter, antipsychotic treatment was switched to amisulpride 200mg at night. She demonstrated a marginal improvement though she starting experiencing parkinsonism at the dose of 600mg twice daily.The woman received trihexyphenidyl. Upon discharge, she still had residual symptoms of psychosis. Subsequently, she was readmitted. The extrapyramidal side effects of amisulpride were still there and she reported amenorrhoea because of hyperprolactinaemia, which were also attributed to amisulpride. Hence, a course of electroconvulsive therapy (ECT) was provided. Amisulpride was changed to quetiapine. Subsequently, she demonstrated significant improvement and was discharged following 3 weeks and was advised to take quetiapine. After 3 months, her menstruation returned and prolactin level normalised. No extrapyramidal symptoms were noted.

show abstract

Case report on Cotard’s syndrome (CS) in a patient with schizophrenia: a rare case from Malaysia

Cited by 2 publications

References 19 publications

Cotard’s Delusion-DEAD MAN’S SKETCH

Cotard’s Delusion-DEAD MAN’S SKETCH

Agomelatine/amisulpride/zolpidem

Contact Info

Product

Resources

About